Collegium Pharmaceutical, Inc. Tax Withholding Paid on Stock Awards
Collegium Pharmaceutical, Inc. (COLL) reported Tax Withholding Paid on Stock Awards of $16.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $646.00K, a 50.93% increase year-over-year.
- Collegium Pharmaceutical, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $15.43M, a 45.69% increase year-over-year.
- Collegium Pharmaceutical, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $861.00K, a 208.60% increase year-over-year.
- Collegium Pharmaceutical, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $964.00K, a 578.87% increase year-over-year.
- Collegium Pharmaceutical, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $12.85M, a 32.99% decline from fiscal 2024.
- Collegium Pharmaceutical, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $19.17M, a 129.28% increase from fiscal 2023.
- Collegium Pharmaceutical, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $8.36M, a 106.75% increase from fiscal 2022.
- Collegium Pharmaceutical, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $4.04M, a 2.53% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $646.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $16.08M 10-Q · filed 2026-08-06 | $16.94M derived: sum of 3 quarters · filed 2026-08-06 | $17.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $15.43M 10-Q · filed 2026-05-07 | $16.29M derived: sum of 2 quarters · filed 2026-05-07 | $17.26M derived: sum of 3 quarters · filed 2026-05-07 | $17.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $861.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.82M derived: sum of 2 quarters · filed 2026-02-26 | $2.25M derived: sum of 3 quarters · filed 2026-08-06 | $12.85M 10-K · filed 2026-02-26 |
| 2025-09-30 | $964.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.39M derived: sum of 2 quarters · filed 2026-08-06 | $11.98M 10-Q · filed 2025-11-06 | $12.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $428.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $11.02M 10-Q · filed 2026-08-06 | $11.30M derived: sum of 3 quarters · filed 2026-08-06 | $11.44M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $10.59M 10-Q · filed 2026-05-07 | $10.87M derived: sum of 2 quarters · filed 2026-05-07 | $11.01M derived: sum of 3 quarters · filed 2026-05-07 | $16.89M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $421.00K derived: sum of 2 quarters · filed 2026-02-26 | $6.30M derived: sum of 3 quarters · filed 2026-02-26 | $19.17M 10-K · filed 2026-02-26 |
| 2024-09-30 | $142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $6.02M derived: sum of 2 quarters · filed 2025-11-06 | $18.89M 10-Q · filed 2025-11-06 | $19.12M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $5.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $18.75M 10-Q · filed 2025-08-07 | $18.98M derived: sum of 3 quarters · filed 2026-02-26 | $19.15M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $12.87M 10-Q · filed 2025-05-08 | $13.11M derived: sum of 2 quarters · filed 2026-02-26 | $13.28M derived: sum of 3 quarters · filed 2026-02-26 | $13.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $405.00K derived: sum of 2 quarters · filed 2026-02-26 | $625.00K derived: sum of 3 quarters · filed 2026-02-26 | $8.36M 10-K · filed 2026-02-26 |
| 2023-09-30 | $172.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $392.00K derived: sum of 2 quarters · filed 2024-11-07 | $8.13M 10-Q · filed 2024-11-07 | $8.17M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $220.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $7.96M 10-Q · filed 2024-08-08 | $8.00M derived: sum of 3 quarters · filed 2025-02-27 | $8.11M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $7.74M 10-Q · filed 2024-05-09 | $7.78M derived: sum of 2 quarters · filed 2025-02-27 | $7.89M derived: sum of 3 quarters · filed 2025-02-27 | $8.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $151.00K derived: sum of 2 quarters · filed 2025-02-27 | $662.00K derived: sum of 3 quarters · filed 2025-02-27 | $4.04M 10-K · filed 2025-02-27 |
| 2022-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $617.00K derived: sum of 2 quarters · filed 2023-11-07 | $4.00M 10-Q · filed 2023-11-07 | $4.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $511.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.89M 10-Q · filed 2023-08-03 | $3.89M derived: sum of 3 quarters · filed 2024-02-22 | $4.11M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $3.38M 10-Q · filed 2023-05-04 | $3.38M derived: sum of 2 quarters · filed 2024-02-22 | $3.60M derived: sum of 3 quarters · filed 2024-02-22 | $4.02M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $220.00K derived: sum of 2 quarters · filed 2024-02-22 | $641.00K derived: sum of 3 quarters · filed 2024-02-22 | $4.15M 10-K · filed 2024-02-22 |
| 2021-09-30 | $220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $641.00K derived: sum of 2 quarters · filed 2022-11-03 | $4.15M 10-Q · filed 2022-11-03 | $4.24M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $421.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.93M 10-Q · filed 2022-08-04 | $4.01M derived: sum of 3 quarters · filed 2023-02-23 | $4.26M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $3.51M 10-Q · filed 2022-05-10 | $3.59M derived: sum of 2 quarters · filed 2023-02-23 | $3.84M derived: sum of 3 quarters · filed 2023-02-23 | $4.41M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $333.00K derived: sum of 2 quarters · filed 2023-02-23 | $897.00K derived: sum of 3 quarters · filed 2023-02-23 | $2.25M 10-K · filed 2023-02-23 |
| 2020-09-30 | $247.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $811.00K derived: sum of 2 quarters · filed 2021-11-04 | $2.17M 10-Q · filed 2021-11-04 | $2.27M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $564.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.92M 10-Q · filed 2021-08-05 | $2.02M derived: sum of 3 quarters · filed 2022-02-24 | $2.22M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $1.36M 10-Q · filed 2021-05-06 | $1.46M derived: sum of 2 quarters · filed 2022-02-24 | $1.66M derived: sum of 3 quarters · filed 2022-02-24 | $1.69M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $299.00K derived: sum of 2 quarters · filed 2022-02-24 | $334.00K derived: sum of 3 quarters · filed 2022-02-24 | $822.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $233.00K derived: sum of 2 quarters · filed 2020-11-05 | $721.00K 10-Q · filed 2020-11-05 | $811.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $523.00K 10-Q · filed 2020-08-05 | $613.00K derived: sum of 3 quarters · filed 2021-02-25 | $727.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $488.00K 10-Q · filed 2020-05-07 | $578.00K derived: sum of 2 quarters · filed 2021-02-25 | $692.00K derived: sum of 3 quarters · filed 2021-02-25 | $832.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $204.00K derived: sum of 2 quarters · filed 2021-02-25 | $344.00K derived: sum of 3 quarters · filed 2021-02-25 | $560.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $254.00K derived: sum of 2 quarters · filed 2019-11-06 | $470.00K 10-Q · filed 2019-11-06 | $470.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $356.00K 10-Q · filed 2019-08-07 | $356.00K derived: sum of 3 quarters · filed 2020-02-27 | $373.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $216.00K 10-Q · filed 2019-05-08 | $216.00K derived: sum of 2 quarters · filed 2020-02-27 | $233.00K derived: sum of 3 quarters · filed 2020-02-27 | $233.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $17.00K derived: sum of 2 quarters · filed 2020-02-27 | $17.00K derived: sum of 3 quarters · filed 2020-02-27 | $68.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $17.00K derived: sum of 2 quarters · filed 2018-11-08 | $68.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $51.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $51.00K 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |